Sumanta K. Pal, MD, City of Hope Cancer Center, discusses the great strides in kidney cancer care that have been made in the past decade.

Throughout the past 10 years, treatment for kidney cancer has continued to evolve, with at least seven new targeted therapies approved, making the survival rate triple. Also, Pal notes that doctors are bringing back immune-based treatment in more targeted and specific ways, which he believes will further improve survival rates for the disease.

Videos

Sumanta K. Pal, MD, City of Hope Cancer Center, discusses the great strides in kidney cancer care that have been made in the past decade. 


Sumanta K. Pal Discusses Strides Made in Kidney Cancer Care

Sumanta K. Pal, MD, City of Hope Cancer Center, discusses the role that nurses will play in the shifting paradigm of cancer treatment.

As immunotherapy continues to become a more popular form of treatment, it is important that nurses act as the first line of communication between the patient and the rest of the healthcare team.

Unlike the side effects of chemotherapy, which tend to appear early in treatment, side effects for immunotherapy may not show up for a number of weeks. Nurses must monitor these side effects and work with physicians to manage them, before they evolve into more serious toxicities.

​Sumanta K. Pal, MD, City of Hope Cancer Center, discusses the role that nurses will play in the shifting paradigm of cancer treatment.


Sumanta K. Pal, MD

Articles

Sumanta K. Pal Discusses Strides Made in Kidney Cancer Care

Sumanta K. Pal on the Role of Nurses in the Shifting Paradigm of Cancer Treatment